Saturna Capital Trimmed Holding in Abbott Laboratories (ABT) as Stock Rose; Apple (AAPL) Shareholder Shikiar Asset Management Has Cut Its Position

Abbott Laboratories (NYSE:ABT) Logo

Shikiar Asset Management Inc decreased its stake in Apple (AAPL) by 7.01% based on its latest 2019Q1 regulatory filing with the SEC. Shikiar Asset Management Inc sold 7,559 shares as the company’s stock rose 12.19% with the market. The institutional investor held 100,259 shares of the computer manufacturing company at the end of 2019Q1, valued at $19.04 million, down from 107,818 at the end of the previous reported quarter. Shikiar Asset Management Inc who had been investing in Apple for a number of months, seems to be less bullish one the $893.67 billion market cap company. The stock increased 0.86% or $1.65 during the last trading session, reaching $194.23. About 16.63 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 1.47% since June 11, 2018 and is uptrending. It has underperformed by 2.96% the S&P500. Some Historical AAPL News: 16/05/2018 – Citing unnamed sources in real estate, law and the North Carolina government, the report said the Research Triangle Park “tops Apple’s short list.”; 01/05/2018 – APPLE CONTINUES TO PLAN FOR ANNUAL DIVIDEND INCREASES; 19/03/2018 – Tech Report: Rumor: Apple could begin making its own micro-LED screens; 18/03/2018 – Samsung, Sharp and others tumble following report Apple is producing its own screens; 30/04/2018 – Apple Inc. vs MEC Resources, LLC | Terminated-Settled | 04/27/2018; 11/05/2018 – Apple says it’s found a ‘revolutionary’ way to make its devices more environmentally friendly; 12/03/2018 – Apple is approaching a trillion dollar valuation Big Apple; 15/05/2018 – APPLE-SAMSUNG BATTLE OVER SMARTPHONE PATENTS REVIVES 2011 FIGHT; 30/05/2018 – Industry giants Apple, Amazon, Google, and Facebook were all founded by first or second generation immigrants; 16/05/2018 – Separately, The Washington Post reported on Wednesday that Virginia Gov. Ralph Northam has also floated areas near Washington D.C., like Crystal City and Tysons, as locales for Apple

Saturna Capital Corp decreased its stake in Abbott Laboratories (ABT) by 1.06% based on its latest 2019Q1 regulatory filing with the SEC. Saturna Capital Corp sold 4,582 shares as the company’s stock rose 2.86% with the market. The institutional investor held 429,078 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $34.30 million, down from 433,660 at the end of the previous reported quarter. Saturna Capital Corp who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $142.88B market cap company. The stock decreased 0.34% or $0.28 during the last trading session, reaching $80.99. About 2.41M shares traded. Abbott Laboratories (NYSE:ABT) has risen 23.36% since June 11, 2018 and is uptrending. It has outperformed by 18.93% the S&P500. Some Historical ABT News: 06/03/2018 – Abbott Labs: FDA OKS Mechanical Heart Valve for Pediatric Patients With Heart Defects; 18/05/2018 – ABBOTT SAYS TWO WEAPONS USED IN ATTACK – SHOTGUN AND .38 REVOLVER, BOTH OBTAINED BY SHOOTER FROM FATHER; 06/03/2018 U.S. FDA SAYS EXPANDED APPROVAL OF A HEART VALVE TO INCLUDE A SIZE SMALL ENOUGH TO BE USED IN NEWBORN PEDIATRIC PATIENTS TO TREAT HEART DEFECTS; 28/03/2018 – ASAHI Receives CTO lndication for Corsair and Coronary Guide Wires; 18/04/2018 – ABBOTT LABORATORIES – QTRLY TOTAL VASCULAR SALES $739 MLN VS $703 MLN REPORTED LAST YEAR; 23/05/2018 – ABBOTT GETS FDA OK FOR XIENCE SIERRA HEART STENT; 11/04/2018 – ABBOTT BEGINS OCT STUDY IN CORONARY ARTERY DISEASE WITH STENT; 28/03/2018 – Abbott is taking its partnership with a diabetes care start-up one step further; 16/04/2018 – Abbott Laboratories expected to post earnings of 58 cents a share – Earnings Preview; 09/04/2018 – Commonwealth’s Kimberly Springsteen-Abbott Honored with 2017 WBEC Leadership Award

Since January 30, 2019, it had 1 buy, and 1 insider sale for $12.17 million activity. 3,455 shares were bought by Stratton John G, worth $249,875.

Saturna Capital Corp, which manages about $3.98 billion and $3.43 billion US Long portfolio, upped its stake in Micron Technology (NASDAQ:MU) by 8,500 shares to 24,491 shares, valued at $1.01M in 2019Q1, according to the filing. It also increased its holding in Pfizer (NYSE:PFE) by 7,417 shares in the quarter, for a total of 1.20 million shares, and has risen its stake in Lowe’s (NYSE:LOW).

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 17. They expect $0.80 EPS, up 9.59% or $0.07 from last year’s $0.73 per share. ABT’s profit will be $1.41B for 25.31 P/E if the $0.80 EPS becomes a reality. After $0.63 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 26.98% EPS growth.

Investors sentiment decreased to 0.82 in 2019 Q1. Its down 0.09, from 0.91 in 2018Q4. It is negative, as 52 investors sold ABT shares while 617 reduced holdings. 143 funds opened positions while 408 raised stakes. 1.26 billion shares or 2.74% less from 1.29 billion shares in 2018Q4 were reported. First Trust holds 0.92% or 115,374 shares in its portfolio. The Virginia-based Greylin Inv Mangement has invested 0.2% in Abbott Laboratories (NYSE:ABT). Regentatlantic Capital Ltd Liability Co stated it has 79,001 shares. Perigon Wealth Management Limited Liability reported 0.24% in Abbott Laboratories (NYSE:ABT). Cubic Asset Management Lc accumulated 0.73% or 30,844 shares. 24,365 are owned by Cohen Klingenstein Ltd. Leisure Capital accumulated 11,619 shares. Van Cleef Asset Managementinc, Ohio-based fund reported 12,800 shares. Of Oklahoma stated it has 0% of its portfolio in Abbott Laboratories (NYSE:ABT). Narwhal Cap holds 59,340 shares. Princeton Port Strategies Group Ltd Com reported 0.36% of its portfolio in Abbott Laboratories (NYSE:ABT). Btc Management invested in 0.04% or 3,243 shares. Rbf Cap Ltd Company has 10,000 shares for 0.09% of their portfolio. Ims Capital has invested 0.91% in Abbott Laboratories (NYSE:ABT). Gilman Hill Asset Limited Liability Co holds 13,733 shares.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Prnewswire.com which released: “Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders – PRNewswire” on May 14, 2019, also Prnewswire.com with their article: “New Data Show Use of Abbott’s FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes – PRNewswire” published on June 08, 2019, Streetinsider.com published: “Abbott Labs (ABT) Growth Target Looks Very Sustainable After Meeting With Management – BMO Capital – StreetInsider.com” on June 06, 2019. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Fool.com and their article: “Better Buy: Abbott Laboratories vs. DexCom – The Motley Fool” published on June 02, 2019 as well as Finance.Yahoo.com‘s news article titled: “At US$78.27, Is It Time To Put Abbott Laboratories (NYSE:ABT) On Your Watch List? – Yahoo Finance” with publication date: May 01, 2019.

Since February 1, 2019, it had 0 buys, and 1 sale for $255,087 activity.

Shikiar Asset Management Inc, which manages about $319.33M and $238.75M US Long portfolio, upped its stake in Gaming And Leisure Properties (NASDAQ:GLPI) by 27,455 shares to 105,340 shares, valued at $4.06M in 2019Q1, according to the filing. It also increased its holding in Ashland Global Holdings Inc by 12,815 shares in the quarter, for a total of 72,185 shares, and has risen its stake in Delta Air Lines Inc (NYSE:DAL).

Investors sentiment decreased to 0.96 in 2019 Q1. Its down 0.01, from 0.97 in 2018Q4. It worsened, as 79 investors sold AAPL shares while 847 reduced holdings. 150 funds opened positions while 735 raised stakes. 2.60 billion shares or 8.28% less from 2.83 billion shares in 2018Q4 were reported. Papp L Roy And Assoc has 4.38% invested in Apple Inc. (NASDAQ:AAPL) for 128,034 shares. Fragasso Group holds 0.85% or 20,871 shares. Eagleclaw Cap Managment Llc has 62,300 shares. Wellcome Tru Limited (The) As Trustee Of The Wellcome Tru holds 9.95% in Apple Inc. (NASDAQ:AAPL) or 3.24 million shares. Regentatlantic Capital Limited Com has invested 2.69% of its portfolio in Apple Inc. (NASDAQ:AAPL). Gardner Russo & Gardner Ltd Liability Corp owns 0% invested in Apple Inc. (NASDAQ:AAPL) for 2,095 shares. Beacon Gp reported 20,777 shares or 0.65% of all its holdings. Qci Asset Mgmt stated it has 183,264 shares. Knott David M accumulated 25,050 shares. Loring Wolcott & Coolidge Fiduciary Advisors Llp Ma owns 535,714 shares for 1.55% of their portfolio. Riverpark Capital Lc owns 98,852 shares. Pinnacle Wealth Mgmt Advisory Group Inc Ltd holds 20,407 shares. Blb&B Advsrs, a Pennsylvania-based fund reported 80,573 shares. Artisan Prtn Ltd Partnership owns 517,002 shares. Cibc Ww stated it has 857,024 shares.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Benzinga.com which released: “Apple’s Stock Technical Outlook Is Brighter Than It May Seem – Benzinga” on May 14, 2019, also Nasdaq.com with their article: “Tuesday Apple Rumors: Apple Isn’t Completely Killing iTunes – Nasdaq” published on June 04, 2019, Seekingalpha.com published: “Apple’s Stock Is Facing Even Steeper Declines – Seeking Alpha” on May 22, 2019. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Nasdaq.com and their article: “After Hours: Broadcom and Apple Sign New Deal, Microsoft Hits All-Time Highs – Nasdaq” published on June 10, 2019 as well as Nasdaq.com‘s news article titled: “Better Buy: Apple vs. Google – Nasdaq” with publication date: June 08, 2019.

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.